Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients

European Journal of Applied Physiology

Volumn 109, Issue 3, 2010, Pages 397-404

  Hansen, Dominique ^a,b   Dendale, Paul ^b,c   Beelen, Milou ^d   Jonkers, Richard A M ^d   Mullens, Annelies ^b   Corluy, Luk ^b   Meeusen, Romain ^a   Van Loon, Luc J C ^d  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b JESSA HOSPITAL   (Belgium)

^c HASSELT UNIVERSITY   (Belgium)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Adipokines; Diabetes; Fat mass; Inflammation; Obesity

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ADIPONECTIN, HUMAN; AUTACOID; BIOLOGICAL MARKER; C REACTIVE PROTEIN; FATTY ACID; IL6 PROTEIN, HUMAN; INTERLEUKIN 6; LEPTIN; RESISTIN; RETN PROTEIN, HUMAN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD; BODY MASS; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; EXERCISE TOLERANCE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; REGRESSION ANALYSIS;

ADIPOKINES; ADIPONECTIN; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; EXERCISE TOLERANCE; FATTY ACIDS, NONESTERIFIED; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LEPTIN; MALE; MIDDLE AGED; OBESITY; REGRESSION ANALYSIS; RESISTIN; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77954865132     PISSN: 14396319     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00421-010-1362-5     Document Type: Article

References (42)

1. Abdelgadir M, Elbagir M, Eltom M, Berne C, Ahrén B (2005) Reduced leptin concentrations in subjects with type 2 diabetes mellitus in Sudan. Metabolism 51:304-306
2. Al-Daghri N, Al-Rubean K, Bartlett WA, Al-Attas O, Jones AF, Kumar S (2003) Serum leptin is elevated in Saudi Arabian patients with metabolic syndrome and coronary artery disease. Diabet Med 20:832-837
3. Al-Harithy RN, Al-Ghamdi S (2005) Serum resistin, adiposity and insulin resistance in Saudi women with type 2 diabetes mellitus. Ann Saudi Med 25:283-287
4. Bahceci M, Gokalp D, Bahceci S, Tuzcu A, Atmaca S, Arikan S (2007) The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high-sensitivity c-reactive protein levels. Is adipocyte size associated with inflammation in adults? J Endocrinol Invest 30:210-214
5. Banerji MA, Faridi N, Atluri R, Chaiken RL, Lebovitz HE (1999) Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metab 84:137-144
6. Bastard JP, Maachi M, Tran Van Nhieu J, Jardel C, Bruckert E, Grimaldi A, Robert JJ, Capeau J, Hainque B (2002) Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 87:2084-2089
7. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B (2006) Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17:4-12
8. Bullo M, Garcia-Lorda P, Salas-Salvado J (2002) Plasma soluble tumor necrosis factor alpha receptors and leptin levels in normalweight and obese women: effect of adiposity and diabetes. Eur J Endocrinol 146:325-331
9. Carey AL, Bruce CR, Sacchetti M, Anderson MJ, Olsen DB, Saltin B, Hawley JA, Febbraio MA (2004) Interleukin-6 and tumor necrosis factor-α are not increased in patients with type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness. Diabetologia 47:1029-1037
10. Carroll JF, Fulda KG, Chiapa AL, Rodriquez M, Phelps DR, Cardarelli KM, Vishwanatha JK, Cardarelli R (2009) Impact or race/ethnicity on the relationship between visceral fat and inflammatory biomarkers. Obesity 17:1420-1427
11. Chanchay S, Tungtrongchitr R, Harnroongroj T, Phonrat B, Rungseesakorn O, Paksanont S, Pooudong S, Saowakontha S, Varongchayakul C (2006) Plasma resistin, insulin concentration in non-diabetic and diabetic, overweight/obese Thai. Int J Vitam Nutr Res 76:125-131
12. Chandalia M, Abate N, Garg A, Strey-Dandersen J, Grundy SM (1999) Relationships between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab 84:2329-2335
13. Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35:1381-1395
14. Fletcher GF, Balady GJ, Amsterdam EA, Chaitman B, Eckel R, Fleg J, Froelicher VF, Leon AS, Piña IL, Rodney R, Simons-Morton DA, Williams MA, Bazzarre T (2001) Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation 104:1694-1740
15. Glickman SG, Marn CS, Supiano MA, Dengel DR (2004) Validity and reliability of dual-energy X-ray absorptiometry for the assessment of abdominal adiposity. J Appl Physiol 97:509-514
16. Haffner SM, Stern MP, Miettinen H, Wei M, Gingerich RL (1996) Leptin concentrations in diabetic and nondiabetic Mexican-Americans. Diabetes 45:822-824
17. Hajer GR, van Haeften TW, Visseren FLJ (2008) Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 29:2959-2971
18. Hasegawa G, Ohta M, Ichida Y, Obayashi H, Shigeta M, Yamasaki M, Fukui M, Yoshikawa T, Nakamura N (2005) Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity. Acta Diabetol 42:104-109
19. Heilbronn LK, Rood J, Janderova L, Albu JB, Kelley DE, Ravussin E, Smith SR (2004) Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J Clin Endocrinol Metab 89:1844-1848
20. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetes patients. Arterioscler Thromb Vasc Biol 20:1595-1599
21. Jensen MD (2008) Role of body fat distribution and the metabolic complications of obesity. J Clin Endocrinol Metab 93:S57-S63
22. Jernas M, Palming J, Sjöholm K, Jennische E, Svensson PA, Gabrielsson BG, Levin M, Sjögren A, Rudemo M, Lystig TC, Carlsson B, Carlsson LM, Lönn M (2006) Seperation of human adipocytes by size: hypertrophic fat cells display distinct gene expression. FASEB J 20:E832-E839
23. Kim C, Park J, Park J, Kang E, Ahn C, Cha B, Lim S, Kim K, Lee H (2006) Comparison of body fat composition and serum adiponectin levels in diabetic obesity and non-diabetic obesity. Obesity 14:1164-1171
24. Kramer H, Cao G, Dugas L, Luke A, Cooper R, Durazo-Arvizu R (2009) Increasing BMI and waist circumference and prevalence of obesity among adults with type 2 diabetes: the National Health and Nutrition Examination Surveys. J Diabetes Complicat [e-pub ahead of print]
25. Lee S, Jensen MD (2009) Adipogenic risk factor differences between Korean and white adults - potential role of plasma free fatty acid and adiponectin. Metabolism 58:270-274
26. Liu J, Askari H, Dagogo-Jack S (1999) Basal and stimulated plasma leptin in diabetic subjects. Obes Res 7:537-544
27. Marita AR, Sarkar JA, Rane S (2005) Type 2 diabetes in non-obese Indian subjects is associated with reduced leptin levels: study from Mumbai, Western India. Mol Cell Biochem 275:143-151
28. Merwe van der MT, Schlaphoff GP, Crowther NJ, Boyd IH, Gray IP, Joffe BI, Lönnroth PN (2001) Lactate and glycerol release from adipose tissue in lean, obese, and diabetic women from South Africa. J Clin Endocrinol Metabol 86:3296-3303
29. Miyazaki Y, Pipek R, Mandarino LJ, DeFronzo RA (2003) Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients. Int J Obes 27:88-94
30. Otto TC, Lande MD (2005) Adipose development: from stem cell to adipocyte. Crit Rev Biochem Mol Biol 40:229-242
31. Putz DM, Goldner WS, Bar RS, Haynes WG, Sivitz WI (2004) Adiponectin and c-reactive protein in obesity, type 2 diabetes, and monodrug therapy. Metabolism 53:1454-1461
32. Rasouli N, Kern PA (2008) Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 93:S64-S73
33. Reimann M, Schutte AE, Schwarz PE (2007) Insulin resistance - the role of ethnicity: evidence from Caucasian and African cohorts. Horm Metab Res 39:853-857
34. Rieusset J, Bouzakri K, Chevillotte E, Ricard N, Jacquet D, Bastard JP, Laville M, Vidal H (2004) Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients. Diabetes 53:2232-2241
35. Sayeed MA, Khan AKA, Mahtab H, Ahsan KA, Banu A, Khanam PA, Ahrén B (2003) Leptin is reduced in lean subjects with type 2 diabetes in Bangladesh. Diabetes Care 26:547
36. Sivitz WI, Wayson SM, Bayless ML, Larson LF, Sinkey C, Bar RS, Haynes WG (2003) Leptin and body fat in type 2 diabetes and monodrug therapy. J Clin Endocrinol Metab 88:1543-1553
37. Skurk T, Alberti-Huber C, Herder C, Hauner H (2007) Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 92:1023-1033
38. Tatti P, Masselli L, Buonanno A, Di Mauro P, Strollo F (2001) Leptin levels in diabetic and nondiabetic subjects. Endocrine 15:305-308
39. Wellen KE, Hotamisligil GS (2003) Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112:1785-1788
40. Yang Y, Lu HL, Zhang J, Yu HY, Wang HW, Zhang MX, Cianflone K (2006) Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs obese type 2 diabetes. Int J Obes 30:439-446
41. You T, Nicklas BJ (2008) Effects of exercise on adipokines and the metabolic syndrome. Curr Diab Rep 8:7-11
42. Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, Olefsky JM (2002) The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 51:2968-2974